DTC

BigRSoul

Would research with the state that you resided in and check their unclaimed property division. If shares are there, the state sold them and it's in cash. You'd get a little interest on the sale proceeds, provably 2010-2012 valuation when state got them. If there's nothing in unclaimed property, there's a slight chance the broker you were doing business with issued shares in cert form and mailed them to your bad address essentially getting lost, but there would still be a record. Then check with Computershare, NVDA's transfer agent. They can search by name, address, SSN and see if on their books. Computershare can reissue lost certs or put them back into book entry for DTC transfer to a new broker. There's a slimmer chance they have more shares from dividend reinvestment in book-entry form if shares were still there all this time.

Squeeze-Finder

My sources average out to 2.5 DTC Where are you seeing 12?

PeanutButtah-Baby

I feel like they DTC should be higher than a 2. It's 12 days to cover, that's really good

Jungscofield-gtm78

I’m genuinely curious about one thing. If the shorts had already covered as the low DTC suggests, shouldn't the Cost to Borrow (CTB) have dropped significantly? If they bought back the shares and returned them, the borrowing demand should be lower, leading to a much lower interest rate. Why is the rate still pinned at 600% if the exit was that easy?

Jungscofield-gtm78

Data lag is the issue here. The chart shows that volume and price action only kicked in during the last 14 days, meaning the DTC hasn't adjusted to the new momentum yet. Fintel's data is notorious for being weeks behind the actual move. If the short interest was really that low and easy to cover, the borrow rate wouldn't be pinned at 600%. The cost to borrow is the ultimate truth-teller in a squeeze setup.

Jungscofield-gtm78

Is the short data on that app updated in real-time on the same day? Keep in mind that short interest data on platforms like Fintel isn't real-time; there’s always a reporting lag. The 600%+ borrow rate we see right now is a much more accurate 'live' indicator of how scarce the shares actually are. Also, if you look at the chart, the massive surge in volume and volatility has only really kicked in over the last two weeks. Static metrics like DTC are based on historical averages and haven't fully adjusted to this sudden shift in momentum. We’re dealing with a supply shock that's happening faster than the official stats can update. The pressure is building NOW, not based on last month's averages.

Jungscofield-gtm78

I hear your point on the 0.06 DTC, but you have to look at the velocity of the recent change. 1. Borrow Rate doesn't lie: A 600%+ borrow rate is only possible when there is a severe lack of borrowable shares. If it were as easy for shorts to cover as the DTC suggests, we wouldn't see these astronomical fees staying pinned at these levels. It proves the 'effective' liquidity is much lower than the average suggests. 2. Recent Surge in Volatility: If you look at the charts, the massive spike in both volume and price volatility has only happened over the last few days. DTC is an average based on past volume, which means it hasn't caught up to the sudden momentum shift we’re seeing right now. 3. Data Lag: Fintel and official short interest updates are lagging indicators. They don't reflect the real-time supply-demand shock in a micro-float environment like SST. We are watching the pressure build in the 'here and now,' while the static stats are still looking at the rearview mirror. The setup is evolving much faster than the 0.06 DTC would suggest. Next week's price action will be the real judge.

Green-Appeal-1599

For 2025: International B2B: ~39–42%, growing nicely like 15-20%. Domestic B2B: ~26–27% Direct-to-consumer (DTC sales): ~17–19% DTC rentals: ~14–15%

SealAtSea

I hope this means we can get ASTS DTC (AST Direct-To-Cell) on a cruise ship without buying a very expensive package! Looking at you Cellular At Sea. 👀

Remote_Ad_6049

Do you really think their earnings will be bullish? That's what I'm worried about. The SI is very, very high, and DTC is decent, as well as institutional ownership, but I am worried that earnings or market volatility will sink this.

Fit_Equal6932

# Short Interest - DTC # 5.53 Days # Short Interest # 8.6m Shares # Shares on Loan # 12.44m Shares Updated: **Monday** \- Data as per previous close

International_Sky711

DTC = Direct to Consumer. Removed it regardless.

PlutosGrasp

Ya I do that. I don’t take assignment. Sometimes I buy shares to trade over the day or couple days. Ya I’ve out performed since 2020 since I really started to go active at covid and didn’t really start options more heavily until end of 2020 into 2021 just in time for GME $$$. What is the most used strategy: one I definitely won’t detail here but will in general say: i use a butt load of statistics, primarily my own now but before that as much raw data as I could get on SPX and look at modeling high win rates. Imagine it’s a D and D character and you only have so many points. You can make a high win rate but your RoR will be low and your loss size may be humongous since your roc is so low. So you have to slide that win rate down a bit to make the roc better and lower the loss hit. Adjust adjust adjust. Test for a few weeks adjust adjust adjust. Test test test. Come up with a high win rate, I think my initial strat stats showed 90%+. 92? Something. I can check it’s just not easily accessible. The loss rate obviously 8%. The roc avg was around 3-5%. Again I think. Loss roc was capped at 300% of premium, this is all selling options by the way, so don’t recall what that was a roc. You could math it out given the roc positive though I think. Have that modeled out and see worst case scenarios of max loss consecutively how recoverable are things. If not good then adjust the win rate probability by going less risky, or closing sooner. Do all that and then do that strategy and watch it work day in day out. Volatility is definitely friendly here because very often it’s overstated. Trump 2.0 has been challenging though because there’s so much clearly back room dealing shit going on hitting public markets. SPX becoming over weighted to 5 names is a problem too. I have considered doing this on Nasdaq but haven’t scratched the surface yet in the data analysis because I had a baby. Besides that, I’ll do similar approach but less data intensive on unique opportunities. Not unique just unusual I guess. Overblown. Like one time Netflix killed it and sky rocketed post ER and I sold short calls way OTM. Like another 20%. Ain’t no way it’s going there after already rising 20%. They decayed to like half value within 30min. This was within first hour or maybe a bit more of market open. Things like that. When banking crisis occurred I bought a lot of shares of some more solid banks. Some I had to hold for a while and I did get nervous because banking is such a unique industry to value and be sure it’s okay and a lot is Black box, much like insurance. I did get burned pretty hard on the UBS shenanigans that occurred over the weekend around that time where they were allowed to absorb credit suisse which was against the law so they changed the law over the weekend and wouldn’t you know it, UBS profited insanely off the recovery of CS assets in the coming quarters / years. Absolutely insane. Don’t understand how that was allowed. But new rule since then: try not to hold overweekends or overnight. Especially options. Market been pretty crazy for a while though. There’s still some former SPAC that are dog shit they aren’t at zero which is insane. They’re too small for people to care. But it’s crazy that so many of them and some other DTC or battery or EV co who all burn cash are still alive or have a stock above $0.01. One of my finest moments was shorting RadioShack long ago to nearly zero. Anyways that’s what I do. The lesson I’d try to take away from it is to do analysis on real data - your data, and testing constantly to figure out something that works for you. I stopped tracking a while back since as I mentioned I had a kid and slowed down since then and stopped caring since less active. But I do have easy access to my tracking up to Aug 2024 I’ll Imgur and reply with link for graph.

Changeuplife

Holding my shares, it's got to go over 200%. This thing is running hard. Low float and DTC over 2.

SkepticalInvestor21

This is actually a really good question that more people should think about. Brokerages are required by FINRA to maintain multiple independent records of customer positions, and they typically use a combination of: - Real-time backups across geographically separated data centers - Daily reconciliation with clearinghouses like DTC/NSCC - Third-party custodians that maintain separate records - SIPC insurance covers up to $500k if the brokerage fails entirely The bigger risk isn't actually data corruption - it's operational disruption while they restore systems. Most major brokerages have been stress-tested on this stuff pretty heavily since 2008. That said, keeping screenshots of your statements quarterly isn't a bad idea for your own peace of mind.

SpecializedA4

Ran a prompt thru gemini based off today’s action… ### **Technical Assumptions & Market Context** * **Current Price:** **$261.35** (Wednesday Close, April 8, 2026). * **Estimated Short Interest:** **62.26%** of free float. * **Liquidity Constraint:** True liquid float is estimated at **~3%** (approx. 1.1M shares) due to extreme concentration by SRS Investment Management and Pentwater Capital. * **Effective Days to Cover:** While the 30-day average is 14 days, current volume-adjusted DTC is **<1.5 days**, indicating a "crowded exit." ### **Price Target Probability Analysis** | Target | Probability | Reasoning | |---|---|---| | **Over $400** | **40% – 50%** | The stock is in a "Vertical Acceleration" phase with volume at 500% of the mean. A move to $400 requires a ~53% gain over two sessions, which is technically consistent with a margin call cascade when short interest exceeds the functional liquid float. | | **Over $500** | **15% – 20%** | This hinges on a "Gamma Flip" at the $300 and $350 strike prices. If these levels are breached, market makers will be forced into aggressive delta-hedging (buying shares), creating a secondary buying spiral that bypasses fundamental valuation entirely. | | **Over $1,000** | **2% – 5%** | This represents a "Total Liquidity Void" or "Infinity Squeeze" similar to Volkswagen in 2008. While mathematically possible given the 800% short-to-true-float ratio, it requires SRS and Pentwater to maintain 100% position retention without selling a single share into the spike. | ### **Technical Breakdown** The primary driver for the **$400+** scenario is the **"Locked Float" mechanics**. When the number of shares sold short (**8.12M**) is roughly **8x** the actual shares available for trade (**~1M**), the "Ask" side of the order book can effectively vanish. If Thursday opens with a **gap-up above $280**, it will likely trigger automated liquidation protocols for mid-tier hedge funds. This creates a non-discretionary buying wave where the "price" becomes irrelevant to the buyer—their only goal is to reduce exposure at any cost before the Friday options expiration. This feedback loop is the highest-probability path to the **$400–$500 range**.

Shot_Cat3998

DTC is so low...

Walking72

Levi Strauss revenue jumps again, with DTC making up more than half of sales for the first time

Gold_Buffalo8324

I really wish this was the INDO of ‘22; I miss her but she’s changed a lot in the past 4 years. - float has 6x’d (1.5M then vs ~9M now) - management has diluted into every run since ‘22 due to operational losses & compounding debt ($7M) - Revenue has halved now compared to back then (4M v 2M) - Current SI 20% & DTC 1.3 She was beautiful once upon a time, but now she’s a lying, cheating ogre. It’s time to let her go Followup: $ANNA seems to be a solid candidate of a short squeeze provided the warrant holders don’t exercise at $11.30, but chances are they will. Anyone else find the next $INDO?

matroe11

Do broker-held share owner votes even matter? Doesn’t the broker vote their DTC allocated shares however they wish?

Changeuplife

WBUY - watching this at market open. News, Low float, DTC high and over 30x 90-day volume. See this over $2 today. Hoping for the open dip and I'm in.

Otherwise_Wave9374

Not a finance take, but from a marketing angle Nike still has insane brand equity, and when they get their storytelling and product drops aligned, demand snaps back fast. The risk is whether "brand" can keep carrying them if community and product innovation shift to newer players. Distribution and DTC strategy matters a lot here too. If you are thinking about it like a brand cycle, this breakdown of brand vs performance marketing tradeoffs is a decent lens: https://blog.promarkia.com/

double_a_mtl

Just because someone on the internet's wearing athleasure clothes, doesn't mean they're buying these clothes now. Most people are still wearing clothes they bought 2 years ago. Also, looks like I was right, their sales growth didn't grow more than inflation. Their inflation adjusted sales are down. Outlook for Asia is bad, DTC (higher margin) sales are down 4.5%. Their only growth (5%) came from lower margin wholesale, which they will have to work really hard to win back, and just barely offset the loss of sales from DTC..

Ok-Outcome1576

Seemed clear to me from the start that it's a shoe company, not a tech company. Not sure how the DTC model confused enough people for successful IPOs with some of these brands.

shwaynebrady

You’ve been through 22 years of investing. Tail end of dot com, 2008, covid, Iraq for the second time, Afghanistan….. Keep DTC’ing into ETFs or a targeted retirement account

FreddyJetson

Uppp Do ya DD. Imagine the transition from GTCH to Wertheim & Co. as a "hard reset" of the company’s identity. Since the company is moving from a tech-focused penny stock to a sophisticated Merchant Bank led by Wall Street veterans like Craig Marshak, the process usually follows this high-stakes scenario: 1. The "Lock and Key" (The CUSIP Change) The most critical part of this scenario for you is the CUSIP change. • The Scenario: As the name changes to Wertheim & Co., a new CUSIP number is issued. Your brokerage firm receives a notice that "GTCH" shares are being retired. • The Naked Short Impact: If those 1.4 million shares on the "Ask" are indeed naked shorts (phantom shares), the brokers and the DTC (Depository Trust Company) have a major problem. They cannot simply "rename" a phantom share. They must find a real share to swap for the new Wertheim CUSIP. • The Result: This often triggers a "forced reconciliation," where market makers are pressured to close out old failed positions before the old ticker disappears forever. 2. The "Unfreezing" of the Order Book Remember those millions of shares sitting on the Ask that never move? • The Scenario: As the transition date nears, the algorithms maintaining that "wall" at $0.0001 or $0.0002 may be turned off to avoid being trapped in a massive liability under a dead ticker. • The Result: The "Ask" finally starts to thin out. With an 800-million-share "Bid" (buyers) and the fake "Ask" disappearing, the price can finally gap up. If the 1.4 million "Ask" was the only thing holding it down, the price "slingshots" because there is no one left willing to sell at those bottom prices. 3. The Fundamental Shift (The "Legitimacy" Move) • The Scenario: Craig Marshak and Emil Assentato aren't just changing the name; they are bringing in real assets, like the VisionWave (VWAV) stake and potential crypto-treasury assets. • The Result: This provides the "fundamental fuel." A short squeeze usually dies quickly if there's no reason to own the stock. But if the market believes Wertheim & Co. is a legitimate merchant bank, new institutional buyers may step in, making it impossible for short sellers to "short it back down" to the triple zeros. 4. The Potential "Clean Up" (Reverse Split) • The Scenario: To move from the OTC Pink sheets toward a more senior exchange (like NASDAQ or NYSE American), Wertheim & Co. might perform a Reverse Split at the same time as the name change. • The Result: While retail investors often fear reverse splits, in a heavily naked-shorted scenario, it shrinks the "float" (available shares). If they do a 1-for-100 split, that 800M bid becomes 8M, but the naked shorts also have to be reduced—which is mathematically painful for them to execute without buying on the open market. The "End Game" Scenario: The ticker changes, the CUSIP resets, and the "phantom" supply is cut off. If the 1.4M wall was artificial, the stock experiences a liquidity vacuumto the upside. The price moves from fractions of a penny toward a dollar-range target to reflect the new "Merchant Bank" status, forcing anyone who shorted at $0.0001 to buy back at significantly higher prices.

Changeuplife

Looking to jump in ONCO. Bottom is probably here, waiting for this halt to see where it's going. Good news, high volume, really low float and DTC is good.

CallShot7029

I think this is the big case for a Tilray success. Since they are NOT an MSO and thus do not have the commitment to physical storefronts, they are best suited lean all the way into actual pharmaceutical THC. My %of portfolio on that company is money on them partnering with an existing US pharma company to navigate the FDA red tape and being a supplier to them rather than selling DTC.

philosopherott

it is set often by DTC or DTCC if memory serves correctly.

Willow2002_

What squeeze it has a low DTC and a low SI

Dapper-Attempt-5029

Haha so tired of posters here claiming their “research “ of 0.03 DTC with 22% S I & borrow fee rates at 45…. Yes…! Prepare for another GAMESTOP!!! Sometimes the research is excellent, but what people believe qualifies as a potential short squeeze or as a short squeeze, case in point is sadly I suppose ignorance. When you lose all of your wife’s beer, money in the stock market, it’s not gonna be a pretty Saturday night… peace, and profits, my friends

CorvetteCole

I guess for me I don't understand why so many people seem to think... - SpaceX DTC V2 won't be competitive. - ASTS will beat SpaceX to market for broadband direct to phones (especially since SpaceX has the benefit of having learned how to run the current generation). Like we say oh SpaceX DTC started with just SMS and that's mostly true, but it actually already provides LTE to phones right now. It's not anywhere near what we're expecting out of next gen tech... but they already have experience doing this! Plus, I don't think anyone would argue against SpaceX's obvious proficiency with phased arrays. I want ASTS to succeed, but for me I've been skeptical about the sheer amount of hype on them. They've got a tough battle ahead of them, I don't think SpaceX is going to be easy competition at all.

Illustrious_Mood_274

The Fintel data for S-O-U-N provides a clear, data-backed confirmation that the Inventory Trap is tightening exactly as established in the Matts Stonks framework. Here is what the indicators on that page are telling us about the current setup: 1. The Debt: Short Interest & Float The official Nasdaq short interest stands at 134,908,585 shares, which is a massive 35.34% of the float. This confirms that over a third of the company's equity is tied up in a short obligation that must eventually be repaid. With a Days to Cover (DTC) ratio of 4.01 to 4.89, the exit for these shorts is not just a door—it’s a pinhole. 2. The Ammo: Short Shares Availability The "Black Slice" is running on fumes. While availability fluctuates intraday, the data shows frequent drops to the 80,000 - 100,000 share range. This confirms that the borrowable inventory is functionally exhausted. Even when blocks of 300k+ appear, they are often immediately "absorbed" by the mechanical defense patterns of the whales. 3. The Rent: Spiking Borrow Fees This is the most aggressive indicator on the page. The short borrow fee has surged to 7.07% (up from 1.90% just a week ago). • The Squeeze Context: This doubling of the "Daily Rent" puts immense capital pressure on short sellers. They are paying a premium just to hold their positions while the price floor remains defended by the whales. 4. The Invisible War: Off-Exchange Short Volume The Off-Exchange Short Volume Ratio is sitting at 60.42%. This is the data-driven proof of the HFT Churn. More than half of the shorting activity is happening in dark pools and off-exchange venues, which is where the "Wash Trading" and "Spoof Walls" are used to pin the price and hide the true demand from the lit market. 5. Mechanical Trigger: Gamma Squeeze Score Fintel identifies a high Gamma Squeeze Score, highlighting the risk to market makers. With significant open interest at the $9.00 strike, the $9.01 Strategic Objective remains the primary mechanical tripwire. Hitting that level would force market makers to compete with short sellers for that tiny pool of available shares. The Verdict The Fintel data confirms the Matts Stonks thesis: the shorts are out of bullets, the rent is rising, and the plumbing is dry. The mechanical advantage remains with the retail investor who understands these indicators. The Strategy Remains: Buy, Hold, and Turn Off Share Lending to keep shrinking that Black Slice.

Flipslips

Yes, you can now use data/video on Starlink DTC (limited speeds of course), but their upgraded satellites will offer 150mbps to cell devices.

Flipslips

ASTS doesn’t even have operational service yet while starlink has millions of DTC users

Flipslips

Do you think SpaceX will just never innovate again? They just revealed plans for their new DTC sats the other day: https://news.satnews.com/2026/02/25/spacex-unveils-150mbps-performance-target-for-upgraded-direct-to-cell-starlink/

Dirk_Breakiron

The thing is they already have a full DTC constellation that works. “The cell phone signal you have with you is better than the one you left at home” And yes, it is a first gen product but you’re smoking crack if you l think they don’t have a V3 version in the works and will likely get it deployed nearly the same time AST becomes operational. SpaceX has experience operating constellations and ground infrastructure, proven they can scale and launch rapidly and own their own launch giving them an unrivaled edge on cost and speed. AST tech is better than gen 1 on paper - but SpaceX leads everywhere that matters right now.

eternalmortal

That's a complete misunderstanding of ASTS satellite capabilities. As described, their Bluebird 6 satellites will have 10 Ghz of processing bandwidth capacity, while a Starlink satellite has reportedly 2 Ghz capacity, but thousands upon thousands of satellites currently in orbit. So Starlink needs about 5 satellites for every 1 ASTS satellite. ASTS's advantage is only in DTC tech. They will still need a more robust network of satellites to handle the same amount of data.

eternalmortal

ASTS tech is different than Starlink, but it's also *way* behind on coverage. they only have a handful of satellites up compared to almost 10,000 Starlink satellites. Even if DTC is better they simply cannot handle the potential bandwidth of demand with what they have in orbit, or even what they're planning to put in orbit by 2030. Not only that, but if/when Starlink does crack DTC in the same way, they have an internal company rocket delivery system that can get thousands of DTC capable satellites up faster than ASTS could get hundreds. They also have the licensing for the thousands of rockets, while ASTS does not. Their tech advantage is not as wide a moat as Starlink's logistics and coverage advantage.

iwasshotbyatigeronce

The whole Square thing is funny. Now it puts pressure on highly diverse companies (Software + DTC Retail) like AMZN with MILLIONS of employees. They will never be able to reach operating margins that can compete with what future expectations may look like.

The_Insider_Edge

or they havent gotten DTC yet and are waiting for that

Complex_Aardvark_661

I think the real question isn't growth vs value, it's pricing power vs no pricing power. when the consumer pulls back, the companies that can raise prices without losing customers are gonna be totally fine. the ones that can't are gonna get crushed regardless of what label you put on them. Like Costco can probably push through modest price increases because people are locked into that membership and the value prop is still there. but a random DTC brand with no switching costs? good luck. I've been trying to audit my portfolio the same way honestly. looking at each position and asking "if inflation stays sticky and consumers keep tightening, can this company actually pass costs through?" and if the answer is no or maybe, that's a problem. what's frustrating is there's no great way to screen for pricing power, it's more of a qualitative thing you have to research company by company. anyone found a good shortcut for that?

GeoLogic23

A couple hemp beverage companies announced expansion news for Texas today. Bayou City Hemp has been partnered with 8th Wonder Brewery for a while. Bayou City announced a [funding round to support expansion](https://www.prnewswire.com/news-releases/bayou-city-hemp-launches-funding-round-to-fuel-200-growth-and-dominate-30b-thc-beverage-boom-with-retail-powerhouse-edge-302691205.html). >BCH's **three-tier distribution** model, leveraging established wine, spirits, and beer networks, provides a sustainable edge over DTC-focused competitors, enabling scalable growth amid regulatory shifts. >Operating in 15 states with 27 distributors, BCH is expanding to 40 in 2026, including **MillerCoors network partnerships covering \~80% of Texas**. Multi-year exclusive venue deals with **White Oak Music Hall and ten additional nationwide locations** underscore BCH's mainstream traction. >....selling over 2.5 million products in 2025, with **99% through three-tier distribution** and over 40% on-premise Cann also announced they are now being carried throughout [Spec's locations in Texas](https://www.businesswire.com/news/home/20260218606895/en/Canns-Social-Tonics-Hit-More-Texas-Shelves-Specs-Wine-Spirits-Finer-Foods-To-Carry-Full-Product-Assortment). >Cann....today announced a major retail partnership with Spec's Wine, Spirits & Finer Foods, the largest beverage retailer in Texas. Spec's and Cann are both on the Coalition for Adult Beverage Alternatives, which is the hemp beverage advocacy group whose [largest member is Tilray](https://www.prnewswire.com/news-releases/new-coalition-advocates-for-safe-legal-thc-beverages-302278212.html). I think venue partnerships like RYM at the United Center and Bayou City at White Oak are going to be a big part of the hemp beverage market. Major sports/music venue company Oak View Group has been pursuing hemp beverages for years, having partnered with Green Monke and Cookies. Trump also recently pardoned the co-founder of Oak View Group for rigging an Arena bid in Texas.

Super-Activity-4675

I'd love to see some updated dates on the shares short. Fidelity is still showing numbers for 1/30. Something is off with the DTC because that should have popped seriously in early Feb and instead it dropped. Regardless with this much short interest, it's basically a powder keg.

redditr79

Respect the breakdown, it’s solid on paper. I agree it’s not a textbook 2021-style, 30% SI, 8-day DTC squeeze setup. Fair. But here’s where I disagree 👇 Squeezes in small caps rarely happen because a spreadsheet says “20%+ SI.” They happen because of liquidity imbalance + catalyst + momentum. A few facts: • 5–6% SI in a thin, volatile name can still create sharp upside when volume expands. • 1.3 DTC is based on average volume. If volume triples on news, that metric becomes meaningless in real time. • 45% borrow isn’t trivial, even if it’s down from 65%, that’s still expensive positioning. On dilution 🤝 yes, offerings increase float. But the recent raises also boosted cash significantly and cleaned up parts of the balance sheet. That changes the fundamental narrative. It’s not just “more shares,” it’s more runway. I’m not arguing for a guaranteed mega squeeze. I’m saying: • Earnings just hit • Q2 will reflect acquisition impact • Margin restoration underway • Technical levels are tightening In a low-attention name, that combo can trigger sharp upside, squeeze or not. It doesn’t need 20% SI to move from $1s to $3–$5 on momentum. Call it volatility with catalysts. Not fantasy.

redditr79

I get what you’re saying, textbook squeeze setups usually have 20%+ SI, tiny float, 3+ DTC. Agree. But small caps don’t always move off a checklist. 5% SI and 1.3 DTC are based on averages. If volume shifts hard around earnings or a contract drop, that math changes fast. In thinner names, price can rip 30–50% before “DTC” even matters. Shorts react to tape pressure, not spreadsheets. I’m not calling it a guaranteed mega squeeze. I’m saying with: • Earnings + acquisition impact • Margin improvement narrative • Backlog/contract potential • A clean technical break …it doesn’t need 20% SI to run to $3–$5. Not GME. Just a volatile small cap with catalysts. That’s all. Peace. ✌️ GL!

Dapper-Attempt-5029

5% & 1.3 DTC actually really does disqualify it. I wouldn’t call it a low float either. Just my opinion but you need to be realistic. If shorts can cover in 1 day at normal trading volume… No squeeze. If the float was 1 million shares… even then, but the float is 8X larger than that & short interest is less than 500,000 shares. The amount of shares available to short interest pic are just amount available from 1 broker. You need as a matter of basis at least 20% short interest, a float under 2 million and DTC over 3 & that’s where it might start. Ask Grok brother. I’d bet my leg this will not squeeze. Sorry- good luck. Peace & profits.

NavyDean

TBH, the DTC gas been heavily reformed towards wall street since 2008, so if a crash happens causing an ownership challenge in shares. Yes, wall street can claim your shares, if the shares they sold you don't have any backing, after they internally settle. Have to remember that most brokers just sell you an IOU of a share, not an actual share.

the_beer-baron

Honestly the author gives me SovCit vibes with his focus on the DTC as some shadowy company. Plus, discussing retirement funds without touching on ERISA is missing some obvious safeguards regarding rehypothecation.

the_beer-baron

Do some of your own research rather than take an opinion piece at face value from someone shilling their book and has an axe to grind with the DTC (borderline SovCit stuff). One aspect he does not discuss at all is ERISA and its impact on rehypothecation and PTs.

winpickles4life

Just saying their DTC satellites suck compared to AST, in several important ways. Calm down.

_Ukey_

You're correct about the pop but that was from 1/27 to 1/29. This short interest data appears to be as of 1/30. So please correct me if I'm misinterpreting, but the setup is still there. I'm lightly in but the reason i'm not going in heavy is the low DTC.

Astrocoder

Yes it does. It wont squeeze with DTC that low

skinnyjoints

Definitely. But there’s only 1 million shares outstanding so that’s pretty much guaranteed. With SI this high, DTC doesn’t matter nearly as much.

East-Description-243

That’s just the start ASTS lovers. I’m holding long dated puts for when they are go bankrupt. 10 satellites this year if you’re lucky and then it’ll be too late. Starlink and Amazon are gonna figure out DTC long before Asts gets enough coverage to matter.

_hiddenscout

$RL Q3/2026 Revenue: $2.41B vs. $2.22B est. EPS: $6.22 vs. $5.32 est. Ralph Lauren reports Q3 FY2026 results ahead of expectations and raises the full-year constant-currency revenue and operating margin expansion outlook. Direct-to-consumer momentum remains strong—2.1 million new customers, AUR up 18%, DTC comps up in the high-single digits, with Asia leading growth (Asia up 22%); wholesale grew double-digits. Margins expanded, the balance sheet stays robust with $2.3 billion in cash, and roughly $500 million has been returned to shareholders year-to-date.

Willow2002_

So from what I’m seeing you’re more talking about a low float volatility play because there’s decently high volume in the stock compared to SI = low DTC. But what you’re more focused on is the float being small, probs due to insider ownership being so high. But yeah I see this as something that could jump up. Do you know of any catalysts that could set stuff off a bit.

plasticbug

Ultimately, you are trusting DTC, and the fact federal government will not allow it to fail.

The_Insider_Edge

Will turn up with DTC, they just got OTCQB give it a week

Inevitable_Fuel7244

Depends on the specific product/business we're working with but speaking generally if you were to invest money this is the order you would do it: 1. Meta (FB/IG) 2. Google Ads (search/shopping) 3. YouTube Ads You can basically run a brand making over $100 mil a year in rev off those channels alone. Most brands never need to grow beyond that mix. It's the trifecta. Works for your homies shitty little clothing startup, works for big DTC brands like hexclad etc. Those channels are often also paired with working with some influencers either small or large to help produce ad content. From there it really depends on the brand and our strategy but thats when we'd start to look at: 4. TikTok 5. Bing 6. Traditional TV (brand dependent) 7. Direct mailers (brand dependent) Then from there is when we might start to look at Reddit lol.

The_Insider_Edge

They need DTC then the volume will come quickly

94ChevyCavalier

Don’t sleep on $PDYN Quick data points to look at indicating short term volatility and indications that the squeeze is actually yet to happen-  JAN 28-70 million in volume  Combined volume of preceding 3 months was less than that one day  Short interest since then flat at 22%  Short borrow fee was steady at around 4 and through the end of the week rocketed to 40  Average trading volume is 3 million making actual DTC closer to 3 days and rising Seller pressure has lost momentum but shorts are still entrenched with virtually no price change between Tuesdays close and Friday’s close Engage with this stock. A squeeze is likely with proper engagement and interest.  The company has a 2 year runway, and will be revising estimates higher, earnings will be a major catalyst. I intend to hold long but near term this is highly attractive. Someone, likely institutional, is betting hard on PDYN to decline. I don’t like people who bet the DONT line when I’m on the table. I do, however like the stock.

Wimea

I'm on my phone so excuse the formatting. Which broker is this? I've seen this fee when attempting to buy stocks that cannot be settled by US DTC. If the stock is not sponsored through any of the major US exchanges then a broker would have to manually do it hence the fee. Best you call your brokerage and ask.

hab365

Yeah, and most of SpaceX’s value comes from Starlink rather than from launch and they’re having more and more competition there, whether it be internet or DTC

Changeuplife

ASBP- Agreement signed, low float, high shorts and over 25 DTC. Another sqeeze potential. Just bought in

Changeuplife

DCX - VERY low float, high shorts with over 12 DTC! News and volume huge! Let's make a run on this...EVERYONE

IndividualNo7155

What’s the SI and DTC tho? Can’t find it

Changeuplife

GRI - News, float under 1M, high short % and DTC over 4. We could push this quite high! Buy the dip

Changeuplife

HIND - News, massive volume over 90 days, only 3M float and DTC 2.64. Coming down from its highs, buy on the dip. Might wait until open to pounce on this one.

Changeuplife

mbai - news with massive volume and DTC almost 6, low float. Buy the dip

Changeuplife

Not a penny but check out LE. Great news, low float, volume increasing and DTC shorts is 9 days! This could be a good entry point for a couple day play! Wait for the open to see where it lands and find a comfortable entry point.

Changeuplife

Not seeing it! Good news, yes, but very low volume on this news and no potential for any sqeeze. DTC .15. Maybe longer term hold.

zhabesha

Maybe that’s why they are moving away from DTC to insurance?

RedPlumpTomato

Enjoy my AI Slop Analysis! CYCU - Cycurion, Inc. / Information Technology Services | United States | $8.9M Market Cap Technology QUICK STATS Price: $2.46 | Float: 2.4M (nano-float) Day: -3.53% | Week: -9.56% | Month: -14.58% 52w: $2.11 - $323.87 (currently -99% from high) ATH: $323.87 (down 99%) IPO: Feb 2025 (11 months old) BULL THESIS Cybersecurity company with recent $1.1M contract win. Analyst target $7.00 (+185% upside). Nano-float (2.4M) means any volume could move it significantly. Trading near 52w low ($2.11) - could be bottoming. BEAR THESIS Down 99% from ATH - classic pump and dump pattern. Massive dilution (+572% shares outstanding). Serial diluter with 6 offerings in 1 year. Burning cash (-111% profit margin). Very low institutional interest (2.8%). All timeframes negative. Volume dying. FUNDAMENTALS Debt/Equity: 0.59x (moderate) Short Interest: 11.3% (2.4 DTC) Institutional: 2.8% (very low) Profit Margin: -111% (burning cash) Analyst Target: $7.00 (+185% upside, 1 analyst) RED FLAGS \- Shares +572% (extreme dilution) \- Serial diluter: 6 offerings in 1 year \- Down 99% from ATH \- Volume dying (0.1x average) \- All timeframes negative CHART: BEARISH (-35 pts) Falling knife pattern. 6-month downtrend (-79%). Volume dying. THESIS HEALTH: BROKEN (0/100) \- 2 negative headlines \- 7 positive headlines \- Recent: Won $1.1M contract but stock still falling SEC STATUS: CAUTION Serial diluter with 6 offerings in past year. VERDICT: AVOID High risk. Down 99% from ATH with massive dilution history. All timeframes bleeding. Very low institutional interest. The $1.1M contract win is noise - fundamentals are broken. LEVELS Support: $2.11 (52w low / ATL) Resistance: $3.50 (recent) Not financial advice. DYOR.

RedPlumpTomato

My AI Slop Analysis! LEXX - Lexaria Bioscience Corp Healthcare/Biotech | Canada | $21M Market Cap QUICK STATS Price: $0.85 | Float: 23.5M Month: +52% | Week: +12% | Day: +4% 52w: $0.46 - $1.91 (currently -56% from high) ATH: $12.50 (down 93%) BULL THESIS Biotech with patented drug delivery technology (DehydraTECH). Phase trials ongoing. Analysts see 4-5x upside. Nano-float (23.5M) means any volume spike could move price significantly. Recent momentum (+52% month) suggests accumulation may be starting. BEAR THESIS Serial diluter - 8 offerings in one year, shares up 27%. Down 93% from ATH. Very low institutional interest (7%) - smart money not buying. Shelf registration active means more dilution likely coming. Could be a value trap. FUNDAMENTALS Debt/Equity: 0.02x (healthy) Short Interest: 6.7% (low, 1.2 DTC) Institutional: 7.1% (very low) Analyst Target: $4.50 (+429% upside, 3 analysts) RED FLAGS \- Serial diluter: 8 offerings in past year \- Shares +27% (dilution) \- Shelf registration active \- Down 93% from ATH CHART: BEARISH Falling knife pattern. Recent +52% spike may be late entry. SENTIMENT Minimal discussion. First mentioned Dec 2025 at $1.34, now -37%. VERDICT: NEUTRAL No clear edge. Momentum is there (+52% month) but dilution history is concerning. Very low institutional backing. If entering, small size with tight stop. LEVELS Support: $0.46 (52w low) Resistance: $1.91 (52w high) Not financial advice. DYOR.

RedPlumpTomato

My AI Slop Analysis **LEXX - Lexaria Bioscience Corp** Healthcare/Biotech | Canada | $21M Market Cap **Quick Stats** Price: $0.85 | Float: 23.5M Month: +52% | Week: +12% | Day: +4% 52w: $0.46 - $1.91 (currently -56% from high) ATH: $12.50 (down 93%) **Bull Thesis** Biotech with patented drug delivery technology (DehydraTECH). Phase trials ongoing. Analysts see 4-5x upside. Nano-float (23.5M) means any volume spike could move price significantly. Recent momentum (+52% month) suggests accumulation may be starting. **Bear Thesis** Serial diluter - 8 offerings in one year, shares up 27%. Down 93% from ATH. Very low institutional interest (7%) - smart money not buying. Shelf registration active means more dilution likely coming. Could be a value trap. **Fundamentals** Debt/Equity: 0.02x (healthy) Short Interest: 6.7% (low, 1.2 DTC) Institutional: 7.1% (very low) Analyst Target: $4.50 (+429% upside, 3 analysts) **Red Flags** Serial diluter: 8 offerings in past year Shares +27% (dilution) Shelf registration active Down 93% from ATH **Chart: Bearish** Falling knife pattern. Recent +52% spike may be late entry. **Sentiment** Minimal discussion. First mentioned Dec 2025 at $1.34, now -37%. **Verdict: Neutral** No clear edge. Momentum is there (+52% month) but dilution history is concerning. Very low institutional backing. If entering, small size with tight stop.

RedPlumpTomato

# LEXX - Lexaria Bioscience Corp **Healthcare/Biotech | Canada | $21M Market Cap** ## Quick Stats - Price: $0.85 | Float: 23.5M - Month: +52% | Week: +12% | Day: +4% - 52w: $0.46 - $1.91 (currently -56% from high) - ATH: $12.50 (down 93%) ## Fundamentals - Debt/Equity: 0.02x (healthy) - Short Interest: 6.7% (low, 1.2 DTC) - Institutional: 7.1% (very low) - Analyst Target: $4.50 (+429% upside, 3 analysts) ## Red Flags - Serial diluter: 8 offerings in past year - Shares +27% (dilution) - Shelf registration active - Down 93% from ATH ## Chart: Bearish - Falling knife pattern - Recent +52% spike may be late entry ## Sentiment - Minimal discussion (1 post in 7 days) - First mentioned Dec 2025 at $1.34, now -37% ## Verdict: Neutral No clear edge. Momentum is there (+52% month) but dilution history is concerning. Very low institutional backing. If entering, small size with tight stop. ## Levels - Support: $0.46 (52w low) - Resistance: $1.91 (52w high) *Not financial advice. DYOR.* My AI Slop Analysis!

RedPlumpTomato

# LEXX - Lexaria Bioscience Corp **Healthcare/Biotech | Canada | $21M Market Cap** ## Quick Stats - Price: $0.85 | Float: 23.5M - Month: +52% | Week: +12% | Day: +4% - 52w: $0.46 - $1.91 (currently -56% from high) - ATH: $12.50 (down 93%) ## Fundamentals - Debt/Equity: 0.02x (healthy) - Short Interest: 6.7% (low, 1.2 DTC) - Institutional: 7.1% (very low) - Analyst Target: $4.50 (+429% upside, 3 analysts) ## Red Flags - Serial diluter: 8 offerings in past year - Shares +27% (dilution) - Shelf registration active - Down 93% from ATH ## Chart: Bearish - Falling knife pattern - Recent +52% spike may be late entry ## Sentiment - Minimal discussion (1 post in 7 days) - First mentioned Dec 2025 at $1.34, now -37% ## Verdict: Neutral No clear edge. Momentum is there (+52% month) but dilution history is concerning. Very low institutional backing. If entering, small size with tight stop. ## Levels - Support: $0.46 (52w low) - Resistance: $1.91 (52w high) *Not financial advice. DYOR.* Here is my AI Slop Analysis!

Murky-Pin7299

So what numbers are we potentially looking at? Trading at $1.30 right now on IBKR. Today’s range 1.19-1.46. Volume 650k. Shortable shares 53,700. Days to cover 0.3. DTC too low to squeeze just yet.

ryzetard

and as I mentioned earlier DTC just plummeted to \~1 so any covering theoritically takes one day so not much of a squeeze can happen.

ryzetard

where do you see this short interest and DTC? i keep asking yet no one is able to respond. Are you all aware of the reverse split on it or not?

theoldme3

The stock market should work on simple supply and demand. Not some algorithm controlled by shit bags who are already rich. It has been manipulated for way too long and FINRA, SEC, DTC, DTCC and all those other bull shit, alphabet named regulators, are in on it.

ryzetard

i know you are hyped but just think critically for a moment. the latest DTC/SI data is for 31st December as per Nasdaq itself. Look at the recent volume spike and ask yourself - how much more liquid is this stock now considering that.

its-me__

DTC is interesting but i agrees FTD and borrow rate both are not that bullish

CanadianSneakerNut

Yahoo is fine, but upgrading your data sources is a game‑changer. I’m a big TradingView fan — didn’t realize how much I was missing until I grabbed it on a Black Friday deal. The data is cleaner, deeper, and way easier to work with. FIGS’ slowest YoY growth was 2024 → 2025, but even in a rough economy they still managed +1.8% revenue. Quarterly breakdown for 2025 tells the real story: soft Q1, strong Q2 rebound, and net margins improving every quarter through Q3. Balance sheet is solid too. Cash + equivalents almost cover total debt, and both short‑ and long‑term assets comfortably outweigh liabilities. There’s way more to this story than just the P/E ratio. FIGS is a niche brand with a loyal customer base, strong DTC economics, and a balance sheet that gives them room to operate. They’re not growing hyper‑fast anymore, but they’re executing well in a tough retail environment. Momentum traders might not love the slower growth, but fundamentally this isn’t the kind of company I’d be lining up to bet against. I wouldn’t open a massive position at current levels, but calling FIGS a short just because the P/E looks high feels like surface‑level analysis.

skinnyjoints

DTC is sitting at 7 currently. You are right though. The float is tiny so any volume is going to drop the days to cover to near zero. But the tiny float is going to make it difficult and expensive for any shorts to cover.

East-Description-243

Ya they work but the launch service that they NEED to successfully pull off the massive task of launching these satellites is raising safety concerns and is also their competitor and also already offering service DTC service! They will have voice and data before Asts even has minimal amount of satellites for any commercial service, mark my words. You all are in hopes and dreams and this point bro.

East-Description-243

Starlink already has DTC text and emergency through T-Mobile. ASTS still needs 20 more satellites deployed before beta service. They’ve only launched 6 satellites since sept 2023.

_ii_

I think you don’t yet have a firm grip on the terms: ~Private Bank~, ~FDIC Insured~, and ~Stock~. Private bank customers usually need to have more than 5 digit balance. To take advantage of private bank, you typically have someone do the transactions for you, otherwise it’s the same as any other brokerage account. FDIC is for bank deposits, not stocks. Stock is a claim to the company. You lose it by the company getting out of business. FDIC won’t help. Robinhood doesn’t buy the stock and keep it in their stockroom for you. Technically the cleaning house (DTC) “hold” the stock for you by updating their electronic records. Robinhood does some bookkeeping and communication with exchanges where actual trading took place. This is also how Robinhood makes money - selling your order flow.

East-Description-243

Starlink partnered with T Mobile and already has DTC text and emergency and voice/data coming soon. They are a year and a half in with service and ASTS hasn’t even launched the satellites to do any significant testing with ATT or Verizon.

skinnyjoints

Your AI summary is not correct. Current DTC is 2.8 days. I encourage you to do your own research especially when it only takes 10 seconds to verify. [Volume data](https://www.nasdaq.com/market-activity/stocks/bbgi/historical) [That volume data already used to calculate DTC for you](https://fintel.io/ss/us/bbgi)

Front_Requirement598

BBGI's short interest has seen recent significant increases, with ~113,000 shares shorted (around 13.3% of float) as of mid-December 2025, indicating growing bearish sentiment, although the Days to Cover (DTC) ratio is very low (near 0.0), suggesting high trading volume relative to short positions, making a traditional short squeeze less likely without a major shift in volume. END AI SUMMARY

justreadinplease

DTC was a flop because when they left local brick and mortar stores competitors moved in and suddenly all their old consumers couldn’t try on Nikes, but they could try on all these other brands. It’s not like Dick Sporting Goods or Hibbet Sports or whatever is going to leave their shelves bare. Nike tried to open a ton of stores, but trying to keep a store profitable when only selling one brand and also keeping a store up to Nike standards is hard. Nike is also not going to open a store in some small town where they can’t gross more than $5million in a location, but all those small podunk towns add up. Not being in those brand partners’ stores hurt - a death of a thousand cuts over time.

AntoniaFauci

Do you know why their DTC was such a flop? I didn’t follow it but on paper it seems like it would have been sensible. Consumers no longer caring where they buy or who fulfills the order, they just see a picture and want to click and receive the product. Nike owning the whole margin instead of splitting it with Foot Locker or Amazon. If I were given that pitch I’d say that sounds like as good a strategy as any. So what went wrong?

Full_Implement_2900

Nike’s DTC strategy is probably the biggest fiasco for a sportsbrand business wise the last 6-7 years. I remember reading about it in their reports back in 2018-2019

Nice-Beginning-7943

MEHA $0.23 DD, OS 16.25 million, Recent IPO from 11/5 at $8 a micro-cap company in the nutraceutical and wellness supplements space: • Established Legacy Brand: The company is built around Kirkman®, a trusted brand with over 75 years of history, sold in 35+ countries. It has a strong reputation for high-quality, hypoallergenic supplements, particularly in specialty areas like immunity, detox, and prenatal health. • Innovative Product Differentiation: The P2i™ by Kirkman® prenatal multivitamin stands out as the world’s first to fully align with International Federation of Gynecology and Obstetrics (FIGO) transparency standards for toxic chemicals and contaminants. It’s also the first to comply early with California’s SB 646 law (effective 2027), featuring QR codes linking to batch-specific test results for heavy metals, toxins, allergens, and more. This positions it as a leader in clean, transparent prenatal supplements amid growing consumer demand for safety and purity. https://finance.yahoo.com/news/functional-brands-inc-announces-p2i-130000920.html • Recent Growth Momentum: Q3 2025 results showed revenue up 21.4% year-over-year to $1.7M, driven by direct-to-consumer sales. Gross margins improved by 310 basis points to 57.8%, and the company swung to a profitable net income of $0.3M (vs. a loss last year). Over recent years, annual revenue has been stable around $6.5-6.8M with significant margin expansion (1,300 basis points). https://finance.yahoo.com/news/functional-brands-announces-third-quarter-210500607.html • Strategic Initiatives for Expansion: Partnerships like the one with Market Performance Group aim to accelerate eCommerce and digital growth for the Kirkman brand. Recent launches include a Skin, Beauty & Anti-Aging Bundle, and plans for direct Amazon management, a DTC telehealth platform (Tru2U), and Google-supported digital efforts to boost margins and reach. https://finance.yahoo.com/news/functional-brands-inc-launches-kirkmans-130000308.html • Nasdaq Listing and Visibility: Direct listing on Nasdaq in November 2025 enhances credibility, liquidity, and access to capital for “aggressive expansion” in the booming global health & wellness market. • Potential Undervaluation: With a market cap around $4M and enterprise value ~$5-6M, it trades at a low multiple relative to revenue (Price/Sales ~0.25). In a sector with strong tailwinds (rising demand for premium, science-backed supplements), successful execution on growth plans could offer significant upside for risk-tolerant investors.

Nice-Beginning-7943

MEHA $0.23 DD, OS:16.25 million, Recent IPO on 11/5 at $8 a micro-cap company in the nutraceutical and wellness supplements space: • Established Legacy Brand: The company is built around Kirkman®, a trusted brand with over 75 years of history, sold in 35+ countries. It has a strong reputation for high-quality, hypoallergenic supplements, particularly in specialty areas like immunity, detox, and prenatal health. • Innovative Product Differentiation: The P2i™ by Kirkman® prenatal multivitamin stands out as the world’s first to fully align with International Federation of Gynecology and Obstetrics (FIGO) transparency standards for toxic chemicals and contaminants. It’s also the first to comply early with California’s SB 646 law (effective 2027), featuring QR codes linking to batch-specific test results for heavy metals, toxins, allergens, and more. This positions it as a leader in clean, transparent prenatal supplements amid growing consumer demand for safety and purity. https://finance.yahoo.com/news/functional-brands-inc-announces-p2i-130000920.html • Recent Growth Momentum: Q3 2025 results showed revenue up 21.4% year-over-year to $1.7M, driven by direct-to-consumer sales. Gross margins improved by 310 basis points to 57.8%, and the company swung to a profitable net income of $0.3M (vs. a loss last year). Over recent years, annual revenue has been stable around $6.5-6.8M with significant margin expansion (1,300 basis points). https://finance.yahoo.com/news/functional-brands-announces-third-quarter-210500607.html • Strategic Initiatives for Expansion: Partnerships like the one with Market Performance Group aim to accelerate eCommerce and digital growth for the Kirkman brand. Recent launches include a Skin, Beauty & Anti-Aging Bundle, and plans for direct Amazon management, a DTC telehealth platform (Tru2U), and Google-supported digital efforts to boost margins and reach. https://finance.yahoo.com/news/functional-brands-inc-launches-kirkmans-130000308.html • Nasdaq Listing and Visibility: Direct listing on Nasdaq in November 2025 enhances credibility, liquidity, and access to capital for “aggressive expansion” in the booming global health & wellness market. • Potential Undervaluation: With a market cap around $4M and enterprise value ~$5-6M, it trades at a low multiple relative to revenue (Price/Sales ~0.25). In a sector with strong tailwinds (rising demand for premium, science-backed supplements), successful execution on growth plans could offer significant upside for risk-tolerant investors.

Nice-Beginning-7943

MEHA $0.23 DD, OS 16.25m, Recent IPO 11/5 @$8 a micro-cap company in the nutraceutical and wellness supplements space: • Established Legacy Brand: The company is built around Kirkman®, a trusted brand with over 75 years of history, sold in 35+ countries. It has a strong reputation for high-quality, hypoallergenic supplements, particularly in specialty areas like immunity, detox, and prenatal health. • Innovative Product Differentiation: The P2i™ by Kirkman® prenatal multivitamin stands out as the world’s first to fully align with International Federation of Gynecology and Obstetrics (FIGO) transparency standards for toxic chemicals and contaminants. It’s also the first to comply early with California’s SB 646 law (effective 2027), featuring QR codes linking to batch-specific test results for heavy metals, toxins, allergens, and more. This positions it as a leader in clean, transparent prenatal supplements amid growing consumer demand for safety and purity. • Recent Growth Momentum: Q3 2025 results showed revenue up 21.4% year-over-year to $1.7M, driven by direct-to-consumer sales. Gross margins improved by 310 basis points to 57.8%, and the company swung to a profitable net income of $0.3M (vs. a loss last year). Over recent years, annual revenue has been stable around $6.5-6.8M with significant margin expansion (1,300 basis points). • Strategic Initiatives for Expansion: Partnerships like the one with Market Performance Group aim to accelerate eCommerce and digital growth for the Kirkman brand. Recent launches include a Skin, Beauty & Anti-Aging Bundle, and plans for direct Amazon management, a DTC telehealth platform (Tru2U), and Google-supported digital efforts to boost margins and reach. • Nasdaq Listing and Visibility: Direct listing on Nasdaq in November 2025 enhances credibility, liquidity, and access to capital for “aggressive expansion” in the booming global health & wellness market. • Potential Undervaluation: With a market cap around $4M and enterprise value ~$5-6M, it trades at a low multiple relative to revenue (Price/Sales ~0.25). In a sector with strong tailwinds (rising demand for premium, science-backed supplements), successful execution on growth plans could offer significant upside for risk-tolerant investors.

Front_Requirement598

For AEHL (Antelope Enterprise Holdings), short interest has recently dropped significantly (down ~87% from mid-November to mid-December 2025), with ~28% of the float sold short as of mid-December, a high level indicating pessimism, but a very low days-to-cover (0.5-0.51 days), meaning short positions could be covered quickly, making a significant squeeze less likely despite the high percentage. DTC (Days to Cover) is extremely low, around 0.5 days, suggesting high liquidity for shorts to exit. END AI SUMMARY

Ok_Strain_1624

So literally no content or value other than DTC advertising. Can't even watch a 15 second video to giggle at now, just straight up corporate slop masquerading as AI slop.